SpineThera, Inc. is a privately held, clinical-stage pharmaceutical company focused on the development of SX600, a novel formulation of extended-release dexamethasone microspheres for epidural injection for the management of lumbar radicular pain. They are also known for their patented micro-suspension platform technology, providing sustained release of the active pharmaceutical ingredient with superior injectability at ultra-high concentrations.